| Mathematics and Statistics | Lifetime | 16 | US 10 | 99.95 |
| Economics and Finance | Lifetime | 534 | US 322 | 99.63 |
| Mathematics and Statistics | 2021-2025 | 13 | US 4 | 99.90 |
| Economics and Finance | 2021-2025 | 769 | US 212 | 96.95 |
| Statistics and Probability | Lifetime | 6 | US 4 | 99.92 |
| Econometrics and Quantitative Economics | Lifetime | 240 | US 149 | 99.72 |
| Infectious Diseases | Lifetime | 603 | US 312 | 97.52 |
| Pathology and Forensic Medicine | Lifetime | 640 | US 291 | 97.14 |
| Statistics, Probability and Uncertainty | Lifetime | 633 | US 238 | 93.33 |
| Statistics and Probability | 2021-2025 | 1 | US 1 | 99.91 |
| Infectious Diseases | 2021-2025 | 77 | US 25 | 98.83 |
| Econometrics and Quantitative Economics | 2021-2025 | 466 | US 98 | 97.42 |
| Oncology | 2021-2025 | 970 | US 407 | 82.44 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 35 | US 18 | 99.84 |
| Advanced Causal Inference Techniques | Lifetime | 4 | US 3 | 99.59 |
| Statistical Methods and Inference | Lifetime | 11 | US 8 | 99.68 |
| Statistical Methods in Clinical Trials | Lifetime | 16 | US 9 | 99.49 |
| Statistical Methods and Bayesian Inference | Lifetime | 15 | US 11 | 99.56 |
| COVID-19 Clinical Research Studies | Lifetime | 226 | US 58 | 98.92 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 235 | US 88 | 99.05 |
| Multiple Sclerosis Research Studies | Lifetime | 428 | US 126 | 97.43 |
| COVID-19 and healthcare impacts | Lifetime | 712 | US 252 | 93.24 |
| HIV-related health complications and treatments | Lifetime | 443 | US 254 | 96.55 |
| Meta-analysis and systematic reviews | Lifetime | 270 | US 80 | 96.18 |
| COVID-19 Impact on Reproduction | Lifetime | 632 | US 254 | 89.56 |
| Bayesian Modeling and Causal Inference | Lifetime | 901 | US 342 | 85.77 |
| Statistical Methods and Inference | 2021-2025 | 1 | US 1 | 99.48 |
| Advanced Causal Inference Techniques | 2021-2025 | 1 | US 1 | 99.75 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 12 | US 3 | 99.65 |
| Statistical Methods in Clinical Trials | 2021-2025 | 2 | US 2 | 99.21 |
| COVID-19 Clinical Research Studies | 2021-2025 | 252 | US 70 | 98.72 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 275 | US 87 | 98.80 |
| Statistical Methods and Bayesian Inference | 2021-2025 | 21 | US 3 | 97.54 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 505 | US 173 | 93.81 |
| COVID-19 Impact on Reproduction | 2021-2025 | 458 | US 169 | 88.27 |
| Meta-analysis and systematic reviews | 2021-2025 | 279 | US 45 | 87.39 |
| HIV-related health complications and treatments | 2021-2025 | 465 | US 196 | 85.61 |
